Robert Mandić

1.8k total citations
70 papers, 1.3k citations indexed

About

Robert Mandić is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Robert Mandić has authored 70 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 28 papers in Oncology and 14 papers in Surgery. Recurrent topics in Robert Mandić's work include Vascular Malformations and Hemangiomas (8 papers), RNA Interference and Gene Delivery (7 papers) and Peptidase Inhibition and Analysis (7 papers). Robert Mandić is often cited by papers focused on Vascular Malformations and Hemangiomas (8 papers), RNA Interference and Gene Delivery (7 papers) and Peptidase Inhibition and Analysis (7 papers). Robert Mandić collaborates with scholars based in Germany, United States and Finland. Robert Mandić's co-authors include Jochen A. Werner, B. Matija Peterlin, Thomas Linnemann, Yong‐Hui Zheng, Susanne Wiegand, Michael Bette, Peter Barth, Behfar Eivazi, Matthias Geyer and Afshin Teymoortash and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Cancer.

In The Last Decade

Robert Mandić

68 papers receiving 1.3k citations

Peers

Countries citing papers authored by Robert Mandić

Since Specialization

Citations

This map shows the geographic impact of Robert Mandić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Mandić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Mandić more than expected).

Fields of papers citing papers by Robert Mandić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Mandić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Mandić. The network helps show where Robert Mandić may publish in the future.

Co-authorship network of co-authors of Robert Mandić

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Mandić. A scholar is included among the top collaborators of Robert Mandić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Mandić. Robert Mandić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres 2025 ·British Journal of Clinical Pharmacology ·(unknown), Anette Drøhse Kjeldsen, Annette Dam Fialla, (unknown), A Guilhem, Elisabetta Buscarini, Freya Droege, Guido Manfredi, (unknown), Jean‐Christophe Saurin, (unknown), (unknown), Martijn C. Post, Robert Mandić, (unknown), Stefan Kasper‐Virchow, Sören Möller, Urban W. Geisthoff, Sophie Dupuis‐Girod	0
2	Generation of a Syngeneic Heterozygous ACVRL1(wt/mut) Knockout iPS Cell Line for the In Vitro Study of HHT2-Associated Angiogenesis 2023 ·Cells ·(unknown), Michael Bette, (unknown), Katrin Roth, (unknown), Boris A. Stuck, Udo Bakowsky, Maria Wartenberg, Heinrich Sauer, Urban W. Geisthoff, Robert Mandić	2
3	Comparison of Whiskbroom and Pushbroom darkfield elastic light scattering spectroscopic imaging for head and neck cancer identification in a mouse model 2021 ·Analytical and Bioanalytical Chemistry ·(unknown), (unknown), Inês Sequeira, Edwin Ostertag, (unknown), Jörg W. Bartsch, Marion Roeßler, Robert Mandić, (unknown), (unknown), Karsten Rebner, Marc Brecht	13
4	Alternative splicing of the TNFSF13B (BAFF) pre-mRNA and expression of the BAFFX1 isoform in human immune cells 2020 ·Gene ·Patrick Stelmach, Michael Pütz, Robert Pollmann, Michael Happel, Susanne Stei, (unknown), Maria Seipelt, (unknown), Rüdiger Eming, Robert Mandić, Magdalena Huber, Björn Tackenberg	5
5	Influence of buffy coat–derived putative endothelial progenitor cells on tumor growth and neovascularization in oral squamous cell carcinoma xenografts 2019 ·Clinical Oral Investigations ·(unknown), Sebastian Blatt, Andreas Pabst, Robert Mandić, Johanna Schwarz, Andreas Neff, Thomas Ziebart	2
6	The Auricular VX2 Carcinoma Is a Suitable Animal Model for Identifying Biomarkers for HNSCC Therapy Response 2018 ·Anticancer Research ·Michael Bette, (unknown), Robert Mandić	1
7	Intraperitoneal Oxidative Stress in Rabbits with Papillomavirus-Associated Head and Neck Cancer Induces Tumoricidal Immune Response That Is Adoptively Transferable 2014 ·Clinical Cancer Research ·(unknown), Robert Mandić, (unknown), H. Höffken, (unknown), Ralf Kinscherf, Eberhard Weihe, Michael Bette	21
8	A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53mut exhibits ATP-binding cassette transporter upregulation and high glutathione levels 2014 ·Journal of Cancer Research and Clinical Oncology ·(unknown), (unknown), (unknown), Michael Bette, (unknown), (unknown), Anne Catherine Bretz, (unknown), Chengzhong Cai, (unknown), Vladimı́r Beneš, Reidar Grénman, Thomas E. Carey, Hermann Lage, Thorsten Stiewe, Andreas Neubauer, Jochen A. Werner, Cornelia Brendel, Robert Mandić	30
9	Intraperitoneal oxidative stress as an oncolytic immunomodulator? 2014 ·OncoImmunology ·Michael Bette, Robert Mandić	0
10	Zellen der Tumorfront: Ein mögliches therapeutisches Ziel bei der Behandlung von Kopf-Hals-Karzinomen? 2013 ·HNO ·(unknown), Robert Mandić	1
11	Zellen der Tumorfront 2013 ·HNO ·(unknown), Robert Mandić	4
12	Intralesional Endoscopy of Advanced Lymphatic Malformations of the Head and Neck 2010 ·Archives of Otolaryngology - Head and Neck Surgery ·Behfar Eivazi, Afshin Teymoortash, Susanne Wiegand, Marion Roeßler, Robert Mandić, Siegfried Bien, Jochen A. Werner	12
13	A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9 2009 ·Oral Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Michael Bette, Jochen A. Werner, Robert Mandić	47
14	Treatment of HNSCC cell lines with the EGFR‐specific inhibitor cetuximab (Erbitux^®) results in paradox phosphorylation of tyrosine 1173 in the receptor 2006 ·FEBS Letters ·Robert Mandić, Chantal Rodgarkia‐Dara, Li Zhu, Benedikt J. Folz, Michael Bette, Eberhard Weihe, Andreas Neubauer, Jochen A. Werner	34
15	Sialadenosis of the Major Salivary Glands in a Patient with Central Diabetes Insipidus - Implications of Aquaporin Water Channels in the Pathomechanism of Sialadenosis 2005 ·Experimental and Clinical Endocrinology & Diabetes ·Robert Mandić, Afshin Teymoortash, Peter Herbert Kann, J. Werner	9
16	Metaanalysis of the significance of matrix metalloproteinases for lymph node disease in patients with head and neck squamous cell carcinoma 2005 ·Cancer ·Susanne Wiegand, Anja A. Dünne, Helge Müller, Robert Mandić, Peter Barth, R. Kim Davis, Jochen A. Werner	42
17	Expression of MMP-3, MMP-13, TIMP-2 and TIMP-3 in the VX2 carcinoma of the New Zealand white rabbit. 2003 ·PubMed ·Robert Mandić, (unknown), (unknown), A. Ramaswamy, Stefan Schulz, Afshin Teymoortash, Andreas M. Sesterhenn, R. Moll, (unknown)	7
18	Subunit H of the V-ATPase Binds to the Medium Chain of Adaptor Protein Complex 2 and Connects Nef to the Endocytic Machinery 2002 ·Journal of Biological Chemistry ·Matthias Geyer, (unknown), Robert Mandić, Thomas Linnemann, Yong‐Hui Zheng, O. Fackler, B. Matija Peterlin	84
19	Interaction between Nef and Phosphatidylinositol-3-Kinase Leads to Activation of p21-Activated Kinase and Increased Production of HIV 2002 ·Virology ·Thomas Linnemann, Yong‐Hui Zheng, Robert Mandić, B. Matija Peterlin	68
20	Characterization of an alternatively spliced isoform of rat vesicle associated membrane protein‐2 (VAMP‐2) 1999 ·FEBS Letters ·Robert Mandić, Anson W. Lowe	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact